Global Corporates at BioTrinity in 2012

BioTrinity 2012 sees more senior business development involvement from Global Pharma and even more involvement from Corporate Venture funds, with an ever great number of the key players being represented from both their BD&L and investment sides, principally attending to look for in-licensing, M&A and investment opportunities.

  • Abbott (European Business Development)

  • Abbott Biotech Ventures (Director, Venture Investments)

  • Amgen (Licensing & Business Development Director)

  • Amgen (VP Clinical Operations)
  • Amgen (Director Research)

  • AstraZeneca (Executive Director, SPBD)

  • AstraZeneca (Director of Business Development x 2)
  • AstraZeneca (Corporate Affairs)
  • AstraZeneca (Vice President, Payer & Real World Evidence)

  • Astellas Pharma Europe (Business and Commercial Development Director)

  • Astellas Venture Mgmt (Investment Director)

  • Biogen Idec (VP Corporate Development, Europe)

  • Boehringer Ingelheim GmbH (Director, Investment Manager)

  • Bristol-Myers Squibb (Head of Europe, Strategic Transactions Group)

  • Eli Lilly (Externalisation Manager, Global External Reseach and Development, Europe)

  • Genzyme (SVP UK & Ireland + South Africa)

  • Goldshield Group (Business Development Manager)

  • GSK (Director of Biology, CEEDD)

  • Inventages (Principal)

  • J&J Dev Corp, US (Vice President, Venture Investments)

  • MedImmune Ventures (Managing Director)

  • Merck & Co, Inc (Executive Director, Licensing and Sr. Director, External Scientific Affairs)

  • Merck Sharpe & Dohme Limited (Senior Director, Licensing and External Research Europe)

  • Merck Research Venture Fund (Managing Director)

  • Merck Serono Ventures (Director)

  • Novartis (Director, Global Alliance Management, Oncology Business Development and Licensing)

  • Novo A/S (Senior Partner)

  • Pfizer (Clinical Affairs Site Head)

  • Shire (SVP Business Development)

  • Shire (Director, Business Development)

  • Shire Strategic Investment Group (SVP)

  • SR One (Partners)

  • Takeda Pharmaceuticals Europe (Senior Director, Global Business Development)

  • Takeda UK (Brand Director - Business Development)

  • Teijin Pharma (General Manager)

  • Teva Pharmaceutical Industries (Director Ex-US Sourcing)